Cardiac tissue engineering represents a groundbreaking field at the intersection of medicine, biology, and engineering, aiming to address the challenges associated with heart diseases and organ transplantation. As a response to the limited availability of donor organs and the intricate nature of the heart, scientists are exploring innovative approaches to create functional cardiac tissues in the laboratory. This involves the use of biomaterials, stem cells, and advanced fabrication techniques to construct three-dimensional structures that mimic the intricate architecture of the heart. The ultimate goal is to develop viable tissue replacements that can integrate seamlessly with the patient's own heart, promoting regeneration and restoring proper cardiac function. This promising avenue holds the potential to revolutionize the treatment of heart diseases, offering personalized solutions and reducing the dependency on traditional transplantation methods. While challenges remain, including achieving electrical integration and vascularization, cardiac tissue engineering represents a beacon of hope in the quest for more effective treatments for cardiovascular disorders.
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Fats of Life, the skinny on statins and beyond !
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Study of pathological cardiac hypertrophy regression
Shuping Zhong, University of Southern California, United States
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Atypical takotsubo cardiomyopathy presenting as st-elevation myocardial infarction
Sana Tariq, Manchester University NHS Foundation Trust, United Kingdom